Pyrotech Therapeutics

Private

BeijingHealthcare & Life Scienceshttps://pyrotech.com/

Last Round

Early Funding

Jul 3, 2026

Total Funding Raised

$97M

Company Overview

Pyrotech Therapeutics is a biotechnology company that develops innovative drugs for the treatment of inflammation and tumors by targeting pyroptosis and innate immune pathways.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryimmunotherapypyroptosissmall-molecule drugsoncolytic virusAI-assisted drug designAIDDinnate immunityclinical-stage biotechbiotech startupdrug pipelineimmunomodulatorsprecision medicinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pyrotech Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Pyrotech Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pyrotech Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Jul 3, 2026
Series A Extension	May 24, 2024
Series A	Jul 10, 2023
Angel	Jan 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

TJ Deng

CEO, Co-founder

Founding Team

Pyrotech Therapeutics Investors

Notable investors and investment history

Pyrotech Therapeutics investors
Investor	Rounds
BioTrack Capital	Series A, Angel
MSA Capital	Series A, Angel
Frees Fund	Series A, Series A Extension, Early Funding, Angel
SDIC Venture Capital	Series A
Lilly Asia Ventures	Series A, Series A Extension, Angel
Zhongguancun Development Group	Angel

View all Investors

Pyrotech Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pyrotech Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pyrotech Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Employee Range13

Year Founded2020

Last FundingJul 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.